FDA
-
-
-
-
-
-
-
InspireMD Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
-
-
-
-
-
-
-
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
-
-
-
-
-
-
-
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
InspireMD (NSPR) Announces Approval of IDE Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System
-
-
-
-
-
-
-
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
-
-
-
-
-
-
-
InspireMD (NSPR) Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
-
327,063 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

